Narrow by location

DOT Changes Drug Testing List

Safety

The U.S. Department of Transportation (DOT) recently issued a final rule that expands the DOT’s current drug testing panel to include some semi-synthetic opioids:

  • Hydrocodon – Trade names Norco, Vicodin, Lortab, Vicoprofen and Riboxen
  • Hydromorphone – Trade name Dilasudid
  • Oxymorphone – Trade name Numorphan
  • Oxycodone – Trade name Eucodal

DOT-regulated employers will be required to test for these highly abused opioids beginning on Jan. 1, 2018.

This change was made to enhance safety, prevent opioid abuse and combat the growing opioid epidemic in the United States. Currently, the DOT requires drug testing of safety-sensitive employees in the transportation industries.

“The opioid crisis is a threat to public safety when it involves safety-sensitive employees involved in the operation of any kind of vehicle or transport,” said Secretary Elaine L. Chao. “The ability to test for a broader range of opioids will advance transportation safety significantly and provide another deterrence to opioid abuse, which will better protect the public and ultimately save lives.”

 

President’s 2019 Budget Represents Strong Commitment to Worker Safety

President Donald J. Trump’s fiscal year 2019 budget request for OSHA supports his continued efforts to assure safe... »

Working Safely With Silica

On September 23, 2017, the US Department of Labor’s Occupational Safety and Health Administration (OSHA) enforced a new... »

Demolition Work Can Be Hazardous to Construction Employees’ Health

By Lauren Masser, Construction Executive In the middle of a hectic morning, a contractor learns there is a... »

Ten Safety Tips for Operating Aerial Work Platforms on Construction Sites

The No. 1 priority for aerial equipment manufacturers is to provide safe, productive aerial work platforms for customers working on aerial worksites. »

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *